Infectious Diseases News and Research

RSS

Nicotinamide may combat antibiotic-resistance staph infections

A new study suggests that nicotinamide, more commonly known as vitamin B3, may be able to combat some of the antibiotic-resistance staph infections that are increasingly common around the world, have killed thousands and can pose a significant threat to public health.

28 Aug 2012

Gilead Sciences receives FDA approval for Stribild to treat HIV-1 infection

Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Stribild (elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), a complete once-daily single tablet regimen for HIV-1 infection for treatment-naïve adults.

28 Aug 2012

BD announces acquisition of Sirigen

BD, a leading global medical technology company, announced today that it has acquired Sirigen Group Limited, a developer of unique polymer dyes that are used in flow cytometry and can be applied to other technologies.

From BD (Becton, Dickinson and Company) 27 Aug 2012

Lunch boxes and school eating areas are hotspots for bacteria

Canadian moms earn top marks when it comes to good hygiene practices, but a new study by Lysol and the Global Hygiene Council reveals they could do more to safeguard against bacteria hotspots in schools, especially at lunch time.

27 Aug 2012

Bleeding risk from aneurysm high in hemorrhagic AVM radiosurgery

In patients undergoing stereotactic radiosurgery for hemorrhagic arteriovenous malformations, endovascular or surgical strategies that reduce bleeding risk should be used if an aneurysm is found, advise US researchers.

24 Aug 2012

Dartmouth’s professor shares news of DAR-901 TB vaccine development

Tuberculosis (TB) is second only to HIV/AIDS as the greatest killer worldwide attributable to a single infectious agent, according to the World Health Organization (WHO). With 8.8 million cases in 2010 and 95 percent of TB deaths occurring in low- and middle-income countries, the disease continues to be a major public health problem in the developing world. In a July address to the International Union Against Tuberculosis and Lung Disease, Dartmouth's C. Fordham (Ford) von Reyn shared news of a promising vaccine in the works.

24 Aug 2012

Diabetes journal reports results from novel experimental therapy

Results from a novel experimental therapy for Type 1 diabetes that boosts parts of the healthy immune system are reported today in the scientific journal Diabetes.

24 Aug 2012

Study highlights importance of using appropriately treated water for sinus irrigation

When water containing the Naegleria fowleri ameba, a single-celled organism, enters the nose, the organisms may migrate to the brain, causing primary amebic meningoencephalitis, a very rare-but usually fatal-disease. A new study published in Clinical Infectious Diseases describes the first reported cases in the United States implicating nasal irrigation using disinfected tap water in these infections.

24 Aug 2012

Researchers discover new way to disarm harmful bacteria

Rather than trying to kill bacteria outright with drugs, Université de Montréal researchers have discovered a way to disarm bacteria that may allow the body's own defense mechanisms to destroy them. "To understand this strategy one could imagine harmful bacteria being like Darth Vader, and the anti-virulence drug would take away his armor and lightsaber," explained Dr. Christian Baron, the study's lead author and Professor at the Department of Biochemistry.

24 Aug 2012

New disease causes AIDS-like symptoms but not spread through virus

"Researchers have identified a mysterious new disease that has left scores of people in Asia and some in the United States with AIDS-like symptoms even though they are not infected with HIV," the Associated Press reports.

24 Aug 2012

The Wistar Institute, MSKCC partner to publish first annotated atlas of Epstein-Barr virus genome

Researchers from The Wistar Institute and Memorial Sloan-Kettering Cancer Center (MSKCC) have teamed to publish the first annotated atlas of the Epstein-Barr virus genome, creating the most comprehensive study of how the viral genome interacts with its human host during a latent infection. Epstein-Barr virus (EBV), which is thought to be responsible for one percent of all human cancers, establishes a latent infection in nearly 100 percent of infected adult humans.

24 Aug 2012

Scripps Research Institute scientist to uncover workings of the immune system

A team led by a scientist at The Scripps Research Institute has received a $22.5 million, five-year project renewal from the National Institutes of Health to uncover the workings of the immune system.

24 Aug 2012

OUP, prestigious Royal Society of Tropical Medicine and Hygiene journals announce partnership

The Royal Society of Tropical Medicine and Hygiene's two prestigious journals will join the Oxford University Press (OUP) collection in a new partnership announced between the organizations.

24 Aug 2012

Concern over ameba-infested tap water deaths

People with sinusitis who regularly treat their condition using nasal irrigation should be aware of a potential contamination risk associated with using inadequately filtered tap water, say US researchers.

23 Aug 2012

National Institute of Allergy and Infectious Diseases announces HIV vaccine initiative awards

"Researchers at 14 institutions will explore new approaches to designing a vaccine against HIV with awards that are part of an anticipated four-year, $34.8 million initiative, the National Institute of Allergy and Infectious Diseases [NIAID] announced Tuesday," the Center for Global Health Policy's "Science Speaks" blog reports.

23 Aug 2012

New results describe development of DC cancer vaccine with enhanced immunogenic potential

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators at Radboud University Nijmegen Medical Centre in the Netherlands announced today that they have published new pre-clinical results in the journal Cancer Immunology Immunotherapy describing the development of a dendritic cell (DC) cancer vaccine with enhanced immunogenic potential.

23 Aug 2012

Aeras, IDRI announce start of first ID93 + GLA-SE Phase I trial for tuberculosis

Aeras and the Infectious Disease Research Institute (IDRI) announce today the start of the first clinical trial of IDRI's novel tuberculosis vaccine candidate, ID93 + GLA-SE.

23 Aug 2012

HIV-related stigma keeps Kenyan pregnant women from having babies in health-care facilities

The fear of being labeled HIV-positive is strong enough to keep mothers in one Kenyan province from having babies in health-care facilities, according to a study published online today in the journal PLOS Medicine. Communities there have come to see clinics and skilled care as mostly for HIV-positive women.

22 Aug 2012

NIAID announces 14 grants for basic research to identify new HIV vaccine approaches

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded 14 grants totaling $7.8 million in first-year funding for basic research to identify new approaches for designing a safe and effective HIV vaccine.

22 Aug 2012

Highly sensitive troponin assay shortens heart attack diagnosis

An algorithm that incorporates high-sensitivity cardiac troponin could allow accurate rule-in and rule-out of patients with acute chest pain within 1 hour of presentation, a study shows.

21 Aug 2012

Infectious Diseases News and Research

Nicotinamide may combat antibiotic-resistance staph infections

Gilead Sciences receives FDA approval for Stribild to treat HIV-1 infection

BD announces acquisition of Sirigen

Lunch boxes and school eating areas are hotspots for bacteria

Bleeding risk from aneurysm high in hemorrhagic AVM radiosurgery

Dartmouth’s professor shares news of DAR-901 TB vaccine development

Diabetes journal reports results from novel experimental therapy

Study highlights importance of using appropriately treated water for sinus irrigation

Researchers discover new way to disarm harmful bacteria

New disease causes AIDS-like symptoms but not spread through virus

The Wistar Institute, MSKCC partner to publish first annotated atlas of Epstein-Barr virus genome

Scripps Research Institute scientist to uncover workings of the immune system

OUP, prestigious Royal Society of Tropical Medicine and Hygiene journals announce partnership

Concern over ameba-infested tap water deaths

National Institute of Allergy and Infectious Diseases announces HIV vaccine initiative awards

New results describe development of DC cancer vaccine with enhanced immunogenic potential

Aeras, IDRI announce start of first ID93 + GLA-SE Phase I trial for tuberculosis

HIV-related stigma keeps Kenyan pregnant women from having babies in health-care facilities

NIAID announces 14 grants for basic research to identify new HIV vaccine approaches

Highly sensitive troponin assay shortens heart attack diagnosis

Industry Focus eBook - Infectious Diseases (3rd Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News